CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-13 | Mutz Christopher HEAD OF RARE DISEASE | Sale 10b5-1 | −3,162 | $71.64 | $227K | 91,309 |
| 2026-03-09 | Mutz Christopher HEAD OF RARE DISEASE | Sale 10b5-1 | −3,602 | $74.18 | $267K | 94,471 |
| 2026-03-07 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes 10b5-1 | −3,314 | $74.04 | $245K | 98,073 |
| 2026-03-06 | Mutz Christopher HEAD OF RARE DISEASE | Sale 10b5-1 | −2,121 | $74.22 | $157K | 101,387 |
| 2026-03-02 | Mutz Christopher HEAD OF RARE DISEASE | Sale 10b5-1 | −417 | $74.00 | $31K | 103,508 |
| 2026-02-28 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −2,221 | $73.90 | $164K | 103,925 |
| 2026-02-26 | Mutz Christopher HEAD OF RARE DISEASE | Grant or award | +21,306 | $77.15 | $1.6M | 106,146 |
| 2026-02-20 | Mutz Christopher HEAD OF RARE DISEASE | Sale 10b5-1 | −5,323 | $78.02 | $415K | 84,840 |
| 2026-02-14 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes 10b5-1 | −2,403 | $77.36 | $186K | 90,163 |
| 2026-02-12 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes 10b5-1 | −3,173 | $76.70 | $243K | 99,598 |
| 2026-02-12 | Mutz Christopher HEAD OF RARE DISEASE | Sale 10b5-1 | −7,032 | $76.55 | $538K | 92,566 |
| 2026-02-11 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −4,546 | $76.25 | $347K | 102,771 |
| 2025-05-14 | Mutz Christopher HEAD OF RARE DISEASE | Sale | −4,000 | $60.45 | $242K | 107,317 |
| 2025-03-07 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −2,874 | $60.62 | $174K | 111,317 |
| 2025-02-28 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,275 | $61.89 | $79K | 114,191 |
| 2025-02-15 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,184 | $58.92 | $70K | 115,466 |
| 2025-02-14 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,473 | $58.92 | $87K | 116,650 |
| 2025-02-12 | Mutz Christopher HEAD OF RARE DISEASE | Grant or award | +24,808 | 101,585 | ||
| 2025-02-12 | Mutz Christopher HEAD OF RARE DISEASE | Grant or award | +16,538 | 118,123 | ||
| 2024-11-15 | Mutz Christopher HEAD OF RARE DISEASE | Sale | −6,500 | $57.70 | $375K | 76,777 |
Page 1 of 2 · 38 trades